OraGraft® Prime – Moldable Demineralized Bone Fibers

Demineralized bone matrices (DBMs) have been used for decades in a wide variety of clinical applications involving bone repair. An ideal DBM provides both osteoinductive and osteoconductive properties, while offering versatile handling capabilities. Additionally, a DBM with angiogenic growth factors further supports new bone formation and healing by facilitating delivery of oxygen and nutrients through new blood vessels.

Comparative Data

Histomorphometric Study of New Bone Formation Comparing Defect Healing with Three Bone Grafting Materials: The Effect of Osteoporosis on Graft Consolidation.
Zhang Q, Jing D, Zhang Y, Miron RJ. Int J Oral Maxillofac Implants. 2018 May/June; 33(3):645–652. PMID: 29420674

Clinical success with allograft use has been reported for the treatment of soft tissue and gingival augmentation. Tissue grafts such as Oracell® are used to provide new gingiva and cover the root.

Allograft bone blocks are a proven alternative to autogenous grafts which have several disadvantages including prolonged operation times, limited graft availability, and risk of damage to adjacent teeth. LifeNet Health’s Dental Allograft Solutions include structural and particulate grafts which provide strength and stability for predictable new bone formation of the alveolar ridge.

Almost 50%  of adults 30 years and older have some form of periodontal disease and the prevalence increases with age. The global economic burden of periodontal disease remains high. The ultimate goal of periodontal therapy relies on the restoration of all components of the periodontium to their original architecture and function (not just bone stabilization).